Context: Non-syndromic cleft lip/palate (NSCL/P) is a congenital anomaly with significant medical, psychological and social ramifications. There is sufficient evidence to hypothesize that locus for this condition can be identified by candidate genes. Aims: The aim of this study is to amplify the chosen region (799 G >T) of MSX 1 gene, investigate the degree of association and perform a mutation research from Raichur cleft lip and palate patient sample. Settings and Design: Case history and clinical examination of the patient were recorded to rule. Written consent was obtained from patients and controls for in vivo study. Study was designed in four steps as follows:
origin. Approximately, two-thirds of the cases are not accompanied by other anomalies and are called non-syndromic (NS). [2] It is very likely that both genetic and environmental factors contribute to this malformation. Genetic factors contribute approximately 30% toward cleft lip and palate, whereas environmental factors are the major contributors approximately 70% of cleft lip and palate. It has been reported that cleft lip and palate occurs more frequently in males while the sex bias is reversed for cleft palate, which is more common in females. [3] The etiology seems complex, but genetics plays a major role.
Over the past decade, genetic linkage and association analyses have provided evidence to support the involvement of several genes and chromosomal regions, among them loci at 1q32 (IRF 6 ), 2p13 (TGFA), 4p16 (MSX 1 ), 6p23-25, 14q24 (TGFB 3 ), 17q21 (RARA) and 19q13 (BCL 3 , TGFB 1 ) have the most supporting data. [4] The development of the head and face is one of the most complex and tightly controlled events during the embryonic development. Disturbances during the period critical for the formation of face (7-10 weeks for humans) may lead to orofacial clefts. [1] Non-syndromic cleft lip with or without cleft palate (NSCL/CLP) is the most common craniofacial anomaly. Its birth prevalence ranges from 1/500 to 1/2000, depending upon geographical
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[Downloaded free from http://www.ijdr.in on Friday, January 02, 2015, IP: 115.111.224.207] || Click here to download free Android application for this journal MSX 1 is located on human chromosome 4p16. The MSX 1 homeobox gene, which is also expressed in the facial primordia, is required for expression of Bmp2 and Bmp4 in the palatal mesenchyme and Sonic Hedgehog (Shh) in the medial edge epithelium (MEE). Shh plays a signifi cant role in the early induction of facial primordia in addition to expression in the palatal MEE. Bmp2 and Bmp4 on the other hand, are expressed more specifi cally within the epithelia and mesenchyme of the palatal shelves. [3] The mutations and polymorphisms of MSX 1 have been shown to be diverse. One of variation for MSX 1 is 799 G > T (G267C).
The advents of molecular biology and advanced genetic techniques have allowed uncovering, characterizing and ultimately manipulating the genes that make up the genome. It is becoming clear that the molecular center of embryogenic morphology resides at the level of gene.
Hence, the aim of this study is to derive an association between MSX 1 799 G > T (G267C) gene variant and NSCL with or without cleft palate in the Raichur district with the use of polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (RFLP) with the restriction enzyme Desulfovibrio desulfuricans (DdEI).
MATERIALS AND METHODS

Source of data
This genetic study was conducted in an Institution on the people of Raichur district having NSCL and palate as cases.
Method of selection of data
Inclusion criteria of patients Patient having NSCL with or without cleft palate.
Inclusion criteria of controls
Subjects should not possess family history of the cleft lip with or without palate, any syndromes related to cleft lip with or without palate and any history of developmental disabilities, including learning disabilities and attention defi cits, hearing impairment and speech defi cits or abnormalities. [5, 6] Exclusion criteria of patients Patients having cleft lip/palate associated with any history of developmental disabilities, including learning disabilities and attention deficits, hearing impairment and speech defi cits or abnormalities. [5, 6] Exclusion criteria of controls Subjects that possess family history of the cleft lip with or without palate, any syndromes related to the cleft lip with or without palate and any history of developmental disabilities, including learning disabilities and attention defi cits, hearing impairment and speech defi cits or abnormalities. [5, 6] 
Sample size
Group A A total of 50 subjects with NSCL, with or without Palate reporting to the cleft clinics of Department of Orthodontics and Dentofacial Orthopedics, AME'S Dental College, Hospital and Research Center from Raichur district.
Group B
A total of 50 unrelated control subjects reporting to the Department of Orthodontics and Dentofacial Orthopedics, AME'S Dental College, Hospital and Research Center from Raichur district.
Methodology
The study was carried out in Department of Orthodontics and Dentofacial Orthopedics, AME'S Dental College, Hospital and Research Center after approval from institutional ethical committee and guidelines from Helsinki declaration were followed. Informed written consent was taken from the respective subjects. A study was conducted on 50 NSCL with or without cleft palate patients and 50 unrelated control subjects. As pre-operative evaluations, all patients were screened for the presence of associated anomalies or syndromes by a geneticist and only those determined to have isolated cleft lip with or without cleft palate were included in the study.
The study was performed in four steps: Collection of blood samples A total volume of 2 ml venous blood samples were obtained from both Group A and Group B and collected in ethylenediaminetetraacetic acid vials and transported in ice box unit [ Figures 1-3 ].
Genomic deoxyribonucleic acid (DNA) extraction
Genomic DNA was extracted from the blood of the cases and control subjects by using ethanol and chloroform protocol [ Figures 4 and 5] . Once the isolated genomic DNA precipitate was obtained, it was used as a template for the PCR test.
PCR
Precipitated genomic DNA was amplifi ed using the PCR with primers: [7] • MSX 1 F: 5′GGCTGATCATGCTCCAATGC3′ • MSX 1 R: 5′CAGGAAACAGCTATGACCCTGGAAG GGGCCAGAGGCTC3'
Giving a PCR product of 448 bases pairs (bp). The PCR product (448 [bp]) that was obtained was run on 1.5% agarose gel containing ethidium bromide to assess the initial amplifi ed PCR products [ Figure 6 ]. (from Desulfovibrio desulfuricans). [7] The digested PCR products were separated into channels on a 1.5% agarose gel containing ethidium bromide in an electrophoretic chamber [ Figures 7 and 8 ]. An ultraviolet transilluminator was used to see the specifi c bands of base pairs of the digested PCR products.
RFLP
Genotyping for the MSX 1 799 G > T gene variant was carried out by restriction digestion of PCR products with DdEI
Statistical analysis
The statistics for this study were computed using the statistical software SPSS (Statistical Package for the Social Sciences), version 17.0, Chicago, IL, USA). Chi-square test was employed for statistical analysis [ Figure 7 ].
RESULTS
The following results were obtained from the descriptive data and the statistical comparisons:
Descriptive data
The initial PCR product of the MSX 1 gene was obtained for the 50 subjects. The size of this PCR product was 448 bp [ Figure 6 ]. After obtaining the initial PCR products of MSX 1 gene (448 bp) from Groups A and B, samples were then subjected to digestion with the specifi c restriction enzyme DdEI. After digestion, the 448 bp products were completely digested with two restriction sites and three specifi c bands at 220, 181 and 150 bp in 44 subjects of Group A [ Figure 7 ], whereas 46 subjects in Group B showed incomplete/no digestion [ Figure 8 ]. Hence, the presence of variant was shown only in 44 subjects of Group A and 4 subjects in Group B.
Statistical comparisons
Chi-square test was employed for statistical analysis that gave a P value of < 0.005 at 95% confi dence intervals. The odds value was 84.3 [ Figure 9 ].
The descriptive data and statistical comparisons demonstrate a signifi cant association between MSX 1 799 G > T (G267C) gene variant and NSCL with or without cleft palate in Raichur patients. 
DISCUSSION
Identifi cation of the genes involved in the development of the human craniofacial region can serve as a fi rst step towards developing a better understanding of diagnosis, treatment and preventions of developmental anomalies of this regions. [8] The genetic background of NSCL/P is complex and most causes remain yet to be identifi ed.
The mammalian MSX gene family consists of 3 physically unlinked members, named MSX 1 , MSX 2 and MSX 3 . However in developing vertebrate embryos, MSX 1 and MSX 2 are widely expressed at the sites where epithelial mesenchymal interactions take place. [9] The process of palatal fusion is also controlled by interactive signaling from the mesenchyme to the epithelium, which is mediated by growth factors and extracellular matrix proteins. One of the key components in this process is MSX 1 expression, which coordinates palatogenesis. The regulation of MSX gene expression is accomplished by diverse mechanisms involving retinoids, antisense "quenching," growth factor regulation and complementary/antagonistic interaction with other transcription factors. This reduced activity of MSX 1 due to genetic variation may increase the risk for oral clefts.
Two previous studies supported that only 2% contribution of MSX 1 to NS clefting. [7] A candidate gene-based association study reported a significant linkage disequilibrium between both CLP and CP with polymorphisms in MSX 1 . In the same report, a cohort of NSCL/P patients were analyzed for coding region mutations without success. [10] In this study, the presence of MSX 1 799 G > T (G267C) gene variant in a sample of 50 subjects was assessed. A signifi cant association was seen in Group A subjects with MSX 1 gene variant as compared with the controls. These findings suggest that these gene variants have a role in the etiology of NSCL/P in our population. In Group B, it was observed that there was no signifi cant association with the gene variant. Hence, this suggest that MSX 1 799 G > T gene variant is positively associated with NSCL and palate in Raichur district. However, there is a possibility of involvement of other genes as NSCL/P is of polygenic nature and studies suggest that other genes such as TGFB3, RARA, BCLX3, TGFαA, MTHR, PVLRI are involved in the etiology of NSCL/P. [1, 11] 
CONCLUSION
This study indicates that there is a strong association between the presence of MSX 1 799 G > T (G267C) gene variant with the incidence of NSCL and palate and it may act as a genetic marker for NSCL and palate in this population.
Studies about such genetic markers of NSCL and palate will help us to predict and target at the molecular level in treating such problems. A major challenge is not only a complete cataloguing of all such genes involved in the etiology of NSCL/P, but identifi cation of their polygenetic nature to have a thorough understanding of the craniofacial development. The future challenge is to bring this new knowledge from the "level of PCR sequencer into the clinical realms ."
